Urokinase plasminogen activator protects cardiac myocytes from oxidative damage and apoptosis via hOGG1 induction. 2017

Philipp J Hohensinner, and Nikol Takacs, and Christoph Kaun, and Barbara Thaler, and Konstantin A Krychtiuk, and Stefan Pfaffenberger, and Arezu Aliabadi, and Andreas Zuckermann, and Kurt Huber, and Johann Wojta
Department of Internal Medicine II, Cardiology, Medical University of Vienna, Währingergürtel 18-20, 1090, Vienna, Austria. philipp.hohensinner@meduniwien.ac.at.

The role of uPA in tissue remodeling and cell migration is already well established. In addition, uPA was reported to stabilize p53, a key cell cycle control, DNA repair and apoptosis initiation protein. We aimed to determine the role of uPA-uPAR signaling towards cell survival or apoptosis in human adult cardiac myocytes (HACM). HACM were stimulated with uPA and DNA damage was inflicted by incubating cells with 200 µM H2O2. To analyze for apoptotic cells we applied TUNEL staining. Oxidative damage foci were analyzed by staining for 8-oxoguanine base pairs. In vivo qPCR analysis from RNA extracted from failing human hearts demonstrated a close relation of uPA with apoptosis and the p53 pathway. Furthermore, we observed a close correlation of uPA and p53 protein in homogenized tissue lysates. In vitro studies revealed that uPA preincubation protected HACM from oxidative damage induced cell death and reduced oxidative damage foci. uPA protection is independent of its catalytic activity, as the amino terminal fragment of uPA showed similar protection. A key enzyme for repairing oxidative DNA damage is the p53 target hOGG1. We found a significant increase of hOGG1 after pretreatment of HACM with uPA. Knockdown of hOGG1 completely abrogated the protective effect of uPA. We conclude that uPA might have a tissue protective role in human hearts besides its role in tissue remodeling. Tissue protection is mediated by the DNA repair protein hOGG1. This might be beneficial during tissue remodeling and thus could be a target for therapeutic approaches in the diseased heart.

UI MeSH Term Description Entries
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006861 Hydrogen Peroxide A strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials. Hydrogen Peroxide (H2O2),Hydroperoxide,Oxydol,Perhydrol,Superoxol,Peroxide, Hydrogen
D014568 Urokinase-Type Plasminogen Activator A proteolytic enzyme that converts PLASMINOGEN to FIBRINOLYSIN where the preferential cleavage is between ARGININE and VALINE. It was isolated originally from human URINE, but is found in most tissues of most VERTEBRATES. Plasminogen Activator, Urokinase-Type,U-Plasminogen Activator,Urinary Plasminogen Activator,Urokinase,Abbokinase,Kidney Plasminogen Activator,Renokinase,Single-Chain Urokinase-Type Plasminogen Activator,U-PA,Single Chain Urokinase Type Plasminogen Activator,U Plasminogen Activator,Urokinase Type Plasminogen Activator
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D016159 Tumor Suppressor Protein p53 Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER. p53 Tumor Suppressor Protein,Cellular Tumor Antigen p53,Oncoprotein p53,TP53 Protein,TRP53 Protein,p53 Antigen,pp53 Phosphoprotein,Phosphoprotein, pp53
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045647 DNA Glycosylases A family of DNA repair enzymes that recognize damaged nucleotide bases and remove them by hydrolyzing the N-glycosidic bond that attaches them to the sugar backbone of the DNA molecule. The process called BASE EXCISION REPAIR can be completed by a DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE which excises the remaining RIBOSE sugar from the DNA. DNA N-glycosidase,DNA Glycosylase,Methylpurine DNA Glycosylase,DNA Glycosylase, Methylpurine,DNA N glycosidase,Glycosylase, DNA,Glycosylase, Methylpurine DNA,Glycosylases, DNA

Related Publications

Philipp J Hohensinner, and Nikol Takacs, and Christoph Kaun, and Barbara Thaler, and Konstantin A Krychtiuk, and Stefan Pfaffenberger, and Arezu Aliabadi, and Andreas Zuckermann, and Kurt Huber, and Johann Wojta
October 2018, Journal of periodontal research,
Philipp J Hohensinner, and Nikol Takacs, and Christoph Kaun, and Barbara Thaler, and Konstantin A Krychtiuk, and Stefan Pfaffenberger, and Arezu Aliabadi, and Andreas Zuckermann, and Kurt Huber, and Johann Wojta
July 2007, European journal of pharmacology,
Philipp J Hohensinner, and Nikol Takacs, and Christoph Kaun, and Barbara Thaler, and Konstantin A Krychtiuk, and Stefan Pfaffenberger, and Arezu Aliabadi, and Andreas Zuckermann, and Kurt Huber, and Johann Wojta
May 2020, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Philipp J Hohensinner, and Nikol Takacs, and Christoph Kaun, and Barbara Thaler, and Konstantin A Krychtiuk, and Stefan Pfaffenberger, and Arezu Aliabadi, and Andreas Zuckermann, and Kurt Huber, and Johann Wojta
January 2019, International journal of clinical and experimental pathology,
Philipp J Hohensinner, and Nikol Takacs, and Christoph Kaun, and Barbara Thaler, and Konstantin A Krychtiuk, and Stefan Pfaffenberger, and Arezu Aliabadi, and Andreas Zuckermann, and Kurt Huber, and Johann Wojta
March 2017, Scientific reports,
Philipp J Hohensinner, and Nikol Takacs, and Christoph Kaun, and Barbara Thaler, and Konstantin A Krychtiuk, and Stefan Pfaffenberger, and Arezu Aliabadi, and Andreas Zuckermann, and Kurt Huber, and Johann Wojta
May 1995, International journal of cancer,
Philipp J Hohensinner, and Nikol Takacs, and Christoph Kaun, and Barbara Thaler, and Konstantin A Krychtiuk, and Stefan Pfaffenberger, and Arezu Aliabadi, and Andreas Zuckermann, and Kurt Huber, and Johann Wojta
April 2007, Biochemical and biophysical research communications,
Philipp J Hohensinner, and Nikol Takacs, and Christoph Kaun, and Barbara Thaler, and Konstantin A Krychtiuk, and Stefan Pfaffenberger, and Arezu Aliabadi, and Andreas Zuckermann, and Kurt Huber, and Johann Wojta
November 2005, Biochemical and biophysical research communications,
Philipp J Hohensinner, and Nikol Takacs, and Christoph Kaun, and Barbara Thaler, and Konstantin A Krychtiuk, and Stefan Pfaffenberger, and Arezu Aliabadi, and Andreas Zuckermann, and Kurt Huber, and Johann Wojta
October 1979, Thrombosis and haemostasis,
Philipp J Hohensinner, and Nikol Takacs, and Christoph Kaun, and Barbara Thaler, and Konstantin A Krychtiuk, and Stefan Pfaffenberger, and Arezu Aliabadi, and Andreas Zuckermann, and Kurt Huber, and Johann Wojta
October 2001, Free radical biology & medicine,
Copied contents to your clipboard!